2024-513002-60-00
CTIS ↗
1001
Non-severe community-acquired pneumonia (CAP) or moderate or severe Coronavirus Disease 2019 (COVID-19)
pharma
Biotest Farmaceutica Ltda
Biotest Pharma GmbH
Biotest Farmaceutica Ltda trial registry — 1 ClinicalTrials.gov studies with program phase, status, and indication context.
Dreieich, DE HQ
2 Employees
EMA registrant Type
Company details
- Status
- Public
- HQ
- Dreieich, DE
- Employees
- 2
- Programs
- 1
- Drugs
- 5
- Patents
- 4
Biotest Farmaceutica Ltda clinical trials
Registry index of 1 ClinicalTrials.gov studies linked to Biotest Farmaceutica Ltda programs — each row shows trial ID, program name, phase, status, and indication.
Biotest Farmaceutica Ltda trial registry — 1 ClinicalTrials.gov studies with program phase, status, and indication context.
Recent trial activity
Latest clinical program signals indexed for Biotest Farmaceutica Ltda.